CORC  > 武汉大学
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study
Wang, Qun; Zhong, Yan-Jun; Yuan, Jing-Ping; Shao, Li-Hua; Zhang, Jue; Tang, Li; Liu, Shao-Ping; Hong, Ya-Ping; Firestone, Raymond A.; Li, Yan
刊名JOURNAL OF TRANSLATIONAL MEDICINE
2013
卷号11
关键词Hepatocellular carcinoma Molecular targeting therapy Doxorubicin PDOX Metastases
ISSN号1479-5876
DOI10.1186/1479-5876-11-192
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4117498
专题武汉大学
推荐引用方式
GB/T 7714
Wang, Qun,Zhong, Yan-Jun,Yuan, Jing-Ping,et al. Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study[J]. JOURNAL OF TRANSLATIONAL MEDICINE,2013,11.
APA Wang, Qun.,Zhong, Yan-Jun.,Yuan, Jing-Ping.,Shao, Li-Hua.,Zhang, Jue.,...&Li, Yan.(2013).Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study.JOURNAL OF TRANSLATIONAL MEDICINE,11.
MLA Wang, Qun,et al."Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study".JOURNAL OF TRANSLATIONAL MEDICINE 11(2013).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace